BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32966290)

  • 1. Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial.
    Mnkugwe RH; Minzi O; Kinung'hi S; Kamuhabwa A; Aklillu E
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008619. PubMed ID: 32966290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial.
    Obonyo CO; Rawago FO; Makworo NK; Muok EMO
    Parasit Vectors; 2024 Jun; 17(1):279. PubMed ID: 38943214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection.
    Obonyo CO; Were VO; Wamae P; Muok EMO
    Trials; 2023 Nov; 24(1):763. PubMed ID: 38012787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan.
    Mohamed AA; Mahgoub HM; Magzoub M; Gasim GI; Eldein WN; Ahmed Ael A; Adam I
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1062-4. PubMed ID: 19261314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
    Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and side effects of praziquantel in the treatment for Schistosoma mansoni infection in school children in Senbete Town, northeastern Ethiopia.
    Reta B; Erko B
    Trop Med Int Health; 2013 Nov; 18(11):1338-43. PubMed ID: 24103059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, Southern Ethiopia.
    Erko B; Degarege A; Tadesse K; Mathiwos A; Legesse M
    Asian Pac J Trop Biomed; 2012 Mar; 2(3):235-9. PubMed ID: 23569905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of multiple Kato-Katz thick smears and a circulating cathodic antigen test for Schistosoma mansoni diagnosis pre- and post-repeated-praziquantel treatment.
    Lamberton PH; Kabatereine NB; Oguttu DW; Fenwick A; Webster JP
    PLoS Negl Trop Dis; 2014 Sep; 8(9):e3139. PubMed ID: 25211217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a Single Oral Dose of Artesunate plus Sulfalene-Pyrimethamineversus Praziquantel in the Treatment of Schistosoma mansoni in Kenyan Children: An Open-Label, Randomized, Exploratory Trial.
    Muok EMO; Were VO; Obonyo CO
    Am J Trop Med Hyg; 2024 Apr; 110(4):677-680. PubMed ID: 38460198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
    Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
    PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors.
    Mueller A; Fuss A; Ziegler U; Kaatano GM; Mazigo HD
    BMC Infect Dis; 2019 Oct; 19(1):832. PubMed ID: 31590657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential analysis of helminth egg output in human stool samples following albendazole and praziquantel administration.
    Scherrer AU; Sjöberg MK; Allangba A; Traoré M; Lohourignon LK; Tschannen AB; N'Goran EK; Utzinger J
    Acta Trop; 2009 Mar; 109(3):226-31. PubMed ID: 19070583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial.
    Obonyo CO; Muok EM; Mwinzi PN
    Lancet Infect Dis; 2010 Sep; 10(9):603-11. PubMed ID: 20705516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST).
    Hoekstra PT; Casacuberta-Partal M; van Lieshout L; Corstjens PLAM; Tsonaka R; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Amoah AS; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008189. PubMed ID: 32196506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial.
    Keiser J; Silué KD; Adiossan LK; N'Guessan NA; Monsan N; Utzinger J; N'Goran EK
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e2975. PubMed ID: 25033291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials.
    Zwang J; Olliaro PL
    PLoS Negl Trop Dis; 2014; 8(11):e3286. PubMed ID: 25412105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acceptability and safety of praziquantel alone and in combination with mebendazole in the treatment of Schistosoma mansoni and soil-transmitted helminthiasis in children aged 1-4 years in Uganda.
    Namwanje H; Kabatereine NB; Olsen A
    Parasitology; 2011 Oct; 138(12):1586-92. PubMed ID: 21349218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.